- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.32 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLU: GLUTAMIC ACID(Non-covalent)
- 1 x 9C0: 9-(4-~{tert}-butylphenyl)-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: L.26, E.27, R.31
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.27
- Water bridges: A:E.24
- Salt bridges: A:R.31
SO4.4: 5 residues within 4Å:- Chain A: A.63, D.139, S.140, K.144, R.148
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:D.139, A:S.140
- Water bridges: A:K.144, A:K.144, A:R.148
- Salt bridges: A:K.144, A:R.148
SO4.8: 5 residues within 4Å:- Chain B: A.63, D.139, S.140, K.144, R.148
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:D.139, B:S.140
- Water bridges: B:S.140, B:K.144, B:R.148
- Salt bridges: B:K.144, B:R.148
SO4.9: 3 residues within 4Å:- Chain B: H.46, K.240, Q.244
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Q.244
- Water bridges: B:K.45
- Salt bridges: B:H.46, B:K.240
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 8 residues within 4Å:- Chain A: G.62, A.63, W.71, T.93, V.95, R.96, S.142, E.145
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:G.62, A:T.93, A:R.96, A:E.145
- Water bridges: A:R.64, A:R.148
GOL.6: 3 residues within 4Å:- Chain A: R.148, W.159, R.163
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.148, A:R.163
GOL.10: 8 residues within 4Å:- Chain B: G.62, A.63, W.71, T.93, V.95, R.96, S.142, E.145
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:G.62, B:T.93, B:T.93, B:R.96, B:E.145
- Water bridges: B:R.64, B:R.148
GOL.11: 5 residues within 4Å:- Chain A: N.214, L.215, D.216, S.217
- Chain B: D.248
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.216
- Water bridges: A:S.217
GOL.12: 3 residues within 4Å:- Chain B: R.148, W.159, R.163
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.148
GOL.13: 5 residues within 4Å:- Chain A: D.248
- Chain B: N.214, L.215, D.216, S.217
5 PLIP interactions:1 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:D.248, B:N.214, B:S.217
- Water bridges: B:S.217, B:S.217
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kunugi, A. et al., TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window. Neuropsychopharmacology (2019)
- Release Date
- 2019-01-16
- Peptides
- Glutamate receptor 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.32 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GLU: GLUTAMIC ACID(Non-covalent)
- 1 x 9C0: 9-(4-~{tert}-butylphenyl)-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kunugi, A. et al., TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window. Neuropsychopharmacology (2019)
- Release Date
- 2019-01-16
- Peptides
- Glutamate receptor 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B